World meat industry news

Rosselkhoznadzor scientists intend to develop analogues of 90% of foreign vaccines registered in the Russian Federation for cattle by 2025. This was announced by the head of the laboratory of biotechnology and the design of viral preparations of the Federal Center for Animal Health (FSBI "ARRIAH" of the Rosselkhoznadzor) Alexander Kononov.

“Imported vaccines for cattle occupy a very small share of the Russian market. In 2022, a total of 29.2 million doses of imported cattle vaccines were imported into Russia. We are faced with the task of developing a whole range of analogue vaccines that would not be inferior to imported ones in terms of efficiency and significance for livestock breeders,” said Alexander Kononov, speaking at a round table at the international exhibition “Meat Industry. Chicken king. Refrigeration Industry for AIC/MAP Russia & VIV 2023”.

The scientist noted that now in the structure of imports of vaccines for cattle, 90% falls on the products of six manufacturers from the USA, Hungary, Spain, the Netherlands and France, which are currently leaving the Russian market. “At the same time, 42.5% of them are drugs for the prevention of clostridial infections in cattle and small cattle. More than 20% - for associated vaccines with leptospirosis. 37% of the market is represented by incomplete analogues of imported vaccines, the use of which makes it possible to prevent the main, economically significant viral diseases of cattle. The development of full analogues is possible in 2024-2025,” he added.

So, in particular, ARRIAH scientists are now developing vaccines against parainfluenza-3, infectious rhinotracheitis, viral diarrhea, respiratory syncytial virus infection (RSVI) and bovine leptospirosis, as well as immunobiological preparations against infectious nodular dermatitis from the Neethling strain. These vaccines will be submitted for registration this year. Next year, it is planned to develop an autovaccine against pasteurellosis, hemophiliasis, colibacillosis in cattle and a vaccine against cow mastitis. In 2025, associated vaccines against bovine viral diseases with the addition of the RSVI antigen, as well as associated vaccines against bovine rotavirus and coronavirus infection with the addition of the Escherichia coli antigen.